ICD-11Criteria for Catatonia Induced by Substances or Medications (6A41) Catatonia induced by substances or medications is a syndrome of primarily psychomotor disturbances, characterized by the co-occurrence of several symptoms of decreased, increased, or abormal psychomotor activity, which develops during or soon after intoxication or withdrawal from certain psychoactive substances, including phencyclidine (PCP), cannabis, hallucinogens such as mescaline or LSD, cocaine and MDMA or related drugs, or during the use of certain psychoactive and non-psychoactive medications (e.g. antipsychotic medications, benzodiazepines, steroids, disulfiram, ciprofloxacin). Exclusions:               Neuroleptic malignant syndrome (BlockL1‑8A0) Serotonin syndrome (8D85)   6A4Z                   Catatonia, unspecified Coding Note:       Code aslo the causing condition REFERENCE: International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022. License: